HMGB1 and telomere syndrome: While we could validate, at least in terms of gene expression, the prognostic value of HMGB1 for trabectedin PFS in advanced STS, we did not perform dynamic studies to analyze the effect of trabectedin treatment in the levels of HMGB1 protein expression.